These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4146864)

  • 1. [Cardiodepressive side effects of beta sympatholytic therapy. Clinical tests with Visken].
    Ohly A; König E; Nachreiner K; Schmidt F
    Med Klin; 1973 May; 68(19):628-34. PubMed ID: 4146864
    [No Abstract]   [Full Text] [Related]  

  • 2. [Duration of effect and dose-response relationship of a new beta-sympatholytic agent in comparison with pindolol in patients with coronary heart disease].
    Becker HJ; Matthäus EJ; Kaltenbach M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1690-4. PubMed ID: 19897
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of tobanum and visken in ischemic heart disease with extrasystole].
    Korkushko OV; Shatilo VB; Butenko AG
    Sov Med; 1989; (12):66-8. PubMed ID: 2483591
    [No Abstract]   [Full Text] [Related]  

  • 4. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Jul; 26(13):1201-5. PubMed ID: 4147032
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-blockers in hypertensive and coronary heart disease.
    Goldstein S
    Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of obsidan for increasing exercise tolerance in elderly patients with ischemic heart disease].
    Kotko DN; Fed'ko GP; Iaroshenko IuT
    Ter Arkh; 1980; 52(8):22-5. PubMed ID: 6114575
    [No Abstract]   [Full Text] [Related]  

  • 8. [Load insufficiency of the heart due to beta receptor blocking agents].
    Froer KL; König E; Grünberg G
    Med Klin; 1969 Sep; 64(37):1663-8. PubMed ID: 4390887
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of congestive heart failure with beta-adrenergic blockers: a brief review of literature.
    Lee YC
    Md Med J; 1998; 47(2):67-71. PubMed ID: 9524413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Every 2nd heart failure patient without beta blocker. "Intolerance" is often a dosage error].
    MMW Fortschr Med; 2003 Feb; 145(6):58. PubMed ID: 12619366
    [No Abstract]   [Full Text] [Related]  

  • 11. Ask the doctor. I have diabetes, coronary artery disease, and heart failure. My doctor wants me to take a beta blocker, but I have heard that these drugs might be dangerous for people like me. Should I follow her advice?
    Lee TH
    Harv Heart Lett; 2002 Oct; 13(2):8. PubMed ID: 12393348
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of atenolol as add-on therapy to fosinopril in heart failure.
    Pacher R; Hülsmann M; Berger R; Koller-Strametz J; Kos T; Frey B; Dukat A; Stanek B
    Wien Klin Wochenschr; 1997 Apr; 109(7):232-8. PubMed ID: 9141231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Finely adjusted differential therapy succeeds this way! References for dose adjustments in heart failure (interview by Dr. Dirk Einecke)].
    Erdmann E
    MMW Fortschr Med; 2005 Sep; 147(39):11. PubMed ID: 16245770
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of the combined use of adrenergic beta receptor blockaders and long-acting nitrates in chronic ischemic heart disease].
    Bragina GI
    Klin Med (Mosk); 1981 Nov; 59(11):36-42. PubMed ID: 6119395
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antihypertensive treatment with beta receptor blockers and obstructive ventilatory disorder (author's transl)].
    Trauth HA
    MMW Munch Med Wochenschr; 1981 Jul; 123(27):1119-21. PubMed ID: 6114427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure.
    Witham MD; Gillespie ND; Struthers AD
    Age Ageing; 2004 Sep; 33(5):467-72. PubMed ID: 15217777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a one-time dose of prolonged-action beta-adrenoblockaders and nitrates on the tolerance of physical loads in ischemic heart disease].
    Ermilov LP; Kuleshova EV; Treshkur TV; Andreeva IV
    Klin Med (Mosk); 1980 Apr; 58(4):77-81. PubMed ID: 6103973
    [No Abstract]   [Full Text] [Related]  

  • 18. [Iatrogenic heart failure].
    Anschütz F
    Fortschr Med; 1979 Oct; 97(38):1647-51. PubMed ID: 41802
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.